Read the FDA Reports about their Fosamax Investigation
Fosamax (Alendronate Sodium), distributed by Merck, was approved by the FDA
in 1995. Since then, there have been many dangerous health risks associated with
those taking the Fosamax drug, including many cases of Osteonecrosis of the Jaw,
also known as Dead Jaw.
This and other dangerous side effects began to
surface as early as 1996. Read the FDA Reports by following the links below:
| Dear Doctor Letter |
| 2001 Fosamax Label Change |
| 2004 Fosamax Label Change |
| 2004 Fosamax Postmarketing Review |
| 2004 FDA Fosamax Event Review |
see also:
2004 Fosamax Label Change
2004 Fosamax Label Change2004 Fosamax Label Change
Dear Doctor (1996)
Dear Doctor - 1996 Letter written to Merck about FosamaxDear Doctor - 1996 Letter written to Merck about Fosamax
Trigeminal Neuralgia
Fosamax & Trigeminal Neuralgia - At risk for neuropathic disorder Trigeminal Neuralgia causes episodes of intense pain- from Fosamax use


